Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5903753 | Metabolism | 2012 | 9 Pages |
Abstract
Overall, these findings indicate that CAPE exhibited anti-inflammatory activity that partly restores normal metabolism, reduces the molecular changes observed in obesity and insulin resistance, and therefore has a potential as a therapeutic agent in obesity.
Keywords
IRS-1COX-2COX-1ALTIRSPMSFPFAIκBIKKHFDOGTTIKKβinhibitor of nuclear factor kappa BIRS-2PKCζprotein kinase Cζanti-phosphotyrosinemTORCAPEFFAJnkc-Jun N-terminal kinaseH&EMAPKNFκBOral glucose tolerance testASTAlanine aminotransferaseEDTAEthylenediaminetetraacetic acidcaffeic acid phenethyl esterFree fatty acidssodium dodecyl sulfate-polyacrylamide gel electrophoresisSDS-PAGEinsulin receptor substrateinsulin receptor substrate-1ANOVAone-way analysis of variancetumor necrosis factor-αstandard error of the meanhigh-fat dietInsulin receptor substrate-2cyclooxygenase-1Cyclooxygenase-2TNF-αnuclear factor kappa BAnti-inflammatory activityphenylmethylsulfonyl fluorideSEMInsulin resistancemammalian target of rapamycinHematoxylin and Eosinparaformaldehydemitogen-activated protein kinasepropolisinsulin receptor
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Rosângela Maria Neves Bezerra, Lucimara Fernanda Veiga, Aline Camila Caetano, Pedro Luiz Rosalen, Maria Esméria Corezola Amaral, Adrianne Christine Palanch, Severino Matias de Alencar,